guest ::
| Home > Publications database > MRI correlates of motoneuron loss in SMA > print |
| 001 | 912540 | ||
| 005 | 20240129202805.0 | ||
| 024 | 7 | _ | |a 10.1007/s00415-022-11326-1 |2 doi |
| 024 | 7 | _ | |a 0012-1037 |2 ISSN |
| 024 | 7 | _ | |a 0340-5354 |2 ISSN |
| 024 | 7 | _ | |a 0939-1517 |2 ISSN |
| 024 | 7 | _ | |a 1432-1459 |2 ISSN |
| 024 | 7 | _ | |a 1619-800X |2 ISSN |
| 024 | 7 | _ | |a 2128/33856 |2 Handle |
| 024 | 7 | _ | |a 36180649 |2 pmid |
| 024 | 7 | _ | |a WOS:000862218800001 |2 WOS |
| 037 | _ | _ | |a FZJ-2022-05713 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Sprenger-Svačina, Alina |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a MRI correlates of motoneuron loss in SMA |
| 260 | _ | _ | |a Heidelberg |c 2023 |b Springer |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2022-10-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2023-01-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2023-01-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1706531782_11227 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a BackgroundMagnetic resonance imaging (MRI) is currently explored as supplemental tool to monitor disease progression and treatment response in various neuromuscular disorders. We here assessed the utility of a multi-parametric magnetic resonance imaging (MRI) protocol including quantitative water T2 mapping, Dixon-based proton density fat fraction (PDFF) estimation and diffusion tensor imaging (DTI) to detect loss of spinal motor neurons and subsequent muscle damage in adult SMA patients.MethodsSixteen SMA patients and 13 age-matched controls were enrolled in this prospective, longitudinal study. All participants underwent MRI imaging including measurements of Dixon-based PDFF and DTI of the sciatic nerve. SMA patients furthermore underwent measurements of muscle water T2 (T2w) of the biceps femoris muscle (BFM) and quadriceps femoris muscle (QFM). Ten participants returned for a second scan six months later. MRI parameter were correlated with clinical data. All patients were on nusinersen treatment.ResultsThere were significantly higher intramuscular fat fractions in the BFM and QFM of SMA patients compared to healthy controls at baseline and after 6 months. Furthermore, T2 values significantly correlated positively with intramuscular fat fractions. The Hammersmith functional motor scale significantly correlated with the QFM’s intramuscular fat fractions. DTI scans of the sciatic nerve were not significantly different between the two groups.ConclusionThis study demonstrates that, water T2 mapping and Dixon-based PDFF estimation may distinguish between adult SMA patients and controls, due to massive intramuscular fat accumulation in SMA. More extensive long-term studies are warranted to further evaluate these two modalities as surrogate markers in SMA patients during treatment. |
| 536 | _ | _ | |a 5251 - Multilevel Brain Organization and Variability (POF4-525) |0 G:(DE-HGF)POF4-5251 |c POF4-525 |f POF IV |x 0 |
| 536 | _ | _ | |a DFG project 431549029 - SFB 1451: Schlüsselmechanismen normaler und krankheitsbedingt gestörter motorischer Kontrolle (431549029) |0 G:(GEPRIS)431549029 |c 431549029 |x 1 |
| 542 | _ | _ | |i 2022-10-01 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 542 | _ | _ | |i 2022-10-01 |2 Crossref |u https://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Haensch, Johannes |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Weiss, Kilian |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Große Hokamp, Nils |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Maintz, David |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Schlamann, Marc |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Fink, Gereon R. |0 P:(DE-Juel1)131720 |b 6 |u fzj |
| 700 | 1 | _ | |a Schloss, Natalie |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Laukamp, Kai |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Wunderlich, Gilbert |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Lehmann, Helmar C. |0 0000-0001-6205-2293 |b 10 |e Corresponding author |
| 700 | 1 | _ | |a Lichtenstein, Thorsten |0 P:(DE-HGF)0 |b 11 |
| 773 | 1 | 8 | |a 10.1007/s00415-022-11326-1 |b Springer Science and Business Media LLC |d 2022-10-01 |n 1 |p 503-510 |3 journal-article |2 Crossref |t Journal of Neurology |v 270 |y 2022 |x 0340-5354 |
| 773 | _ | _ | |a 10.1007/s00415-022-11326-1 |0 PERI:(DE-600)1421299-7 |n 1 |p 503-510 |t Journal of neurology |v 270 |y 2023 |x 0367-004x |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/912540/files/PDF.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:912540 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 6 |6 P:(DE-Juel1)131720 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5251 |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2022-11-12 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2022-11-12 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-12 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-12 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-21 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROL : 2022 |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J NEUROL : 2022 |d 2023-10-21 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |a 10.1016/j.nmd.2017.11.005 |9 -- missing cx lookup -- |1 E Mercuri |p 103 - |2 Crossref |u Mercuri E, Finkel RS, Muntoni F et al (2018) Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 28:103–115. https://doi.org/10.1016/j.nmd.2017.11.005 |t Neuromuscul Disord |v 28 |y 2018 |
| 999 | C | 5 | |a 10.1080/20016689.2019.1601484 |9 -- missing cx lookup -- |1 DC Malone |p 1601484 - |2 Crossref |u Malone DC, Dean R, Arjunji R et al (2019) Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients. J Mark Access Heal Policy 7:1601484. https://doi.org/10.1080/20016689.2019.1601484 |t J Mark Access Heal Policy |v 7 |y 2019 |
| 999 | C | 5 | |a 10.1007/s12325-019-00923-8 |1 O Dabbous |9 -- missing cx lookup -- |2 Crossref |u Dabbous O, Maru B, Jansen JP et al (2019) Survival, motor function, and motor milestones: comparison of AVXS-101 relative to nusinersen for the treatment of infants with spinal muscular atrophy type 1. Adv Ther. https://doi.org/10.1007/s12325-019-00923-8 |t Adv Ther |y 2019 |
| 999 | C | 5 | |a 10.1056/nejmoa1702752 |9 -- missing cx lookup -- |1 RS Finkel |p 1723 - |2 Crossref |u Finkel RS, Mercuri E, Darras BT et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723–1732. https://doi.org/10.1056/nejmoa1702752 |t N Engl J Med |v 377 |y 2017 |
| 999 | C | 5 | |a 10.3390/jcm9072222 |9 -- missing cx lookup -- |1 S Messina |p 2222 - |2 Crossref |u Messina S, Sframeli M (2020) New treatments in spinal muscular atrophy: positive results and new challenges. J Clin Med 9:2222. https://doi.org/10.3390/jcm9072222 |t J Clin Med |v 9 |y 2020 |
| 999 | C | 5 | |a 10.1111/ene.14472 |9 -- missing cx lookup -- |1 B Stolte |p 2586 - |2 Crossref |u Stolte B, Bois JM, Bolz S et al (2020) Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy. Eur J Neurol 27:2586–2594. https://doi.org/10.1111/ene.14472 |t Eur J Neurol |v 27 |y 2020 |
| 999 | C | 5 | |a 10.1371/journal.pone.0172346 |1 D Ramsey |9 -- missing cx lookup -- |2 Crossref |u Ramsey D, Scoto M, Mayhew A et al (2017) Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool. PLoS ONE. https://doi.org/10.1371/journal.pone.0172346 |t PLoS ONE |y 2017 |
| 999 | C | 5 | |a 10.1007/s00415-019-09646-w |9 -- missing cx lookup -- |1 C Brogna |p 898 - |2 Crossref |u Brogna C, Cristiano L, Verdolotti T et al (2020) MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients. J Neurol 267:898–912. https://doi.org/10.1007/s00415-019-09646-w |t J Neurol |v 267 |y 2020 |
| 999 | C | 5 | |a 10.1002/NBM.4357 |1 LAM Otto |9 -- missing cx lookup -- |2 Crossref |u Otto LAM, van der Pol W, Schlaffke L et al (2020) Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3. Nmr Biomed. https://doi.org/10.1002/NBM.4357 |t Nmr Biomed |y 2020 |
| 999 | C | 5 | |a 10.1371/journal.pone.0201004 |1 A Chabanon |9 -- missing cx lookup -- |2 Crossref |u Chabanon A, Seferian AM, Daron A et al (2018) Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS ONE. https://doi.org/10.1371/journal.pone.0201004 |t PLoS ONE |y 2018 |
| 999 | C | 5 | |a 10.1002/acn3.406 |9 -- missing cx lookup -- |1 U Bonati |p 292 - |2 Crossref |u Bonati U, Holiga Š, Hellbach N et al (2017) Longitudinal characterization of biomarkers for spinal muscular atrophy. Ann Clin Transl Neurol 4:292–304. https://doi.org/10.1002/acn3.406 |t Ann Clin Transl Neurol |v 4 |y 2017 |
| 999 | C | 5 | |a 10.1016/j.nmd.2016.07.013 |9 -- missing cx lookup -- |1 A Mankodi |p 650 - |2 Crossref |u Mankodi A, Bishop CA, Auh S et al (2016) Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy. Neuromuscul Disord 26:650–658. https://doi.org/10.1016/j.nmd.2016.07.013 |t Neuromuscul Disord |v 26 |y 2016 |
| 999 | C | 5 | |a 10.1016/j.nmd.2014.02.009 |9 -- missing cx lookup -- |1 PG Carlier |p 390 - |2 Crossref |u Carlier PG (2014) Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: Different methodology, different information and different implications. Neuromuscul Disord 24:390–392. https://doi.org/10.1016/j.nmd.2014.02.009 |t Neuromuscul Disord |v 24 |y 2014 |
| 999 | C | 5 | |a 10.1002/acn3.502 |9 -- missing cx lookup -- |1 T Lichtenstein |p 19 - |2 Crossref |u Lichtenstein T, Sprenger A, Weiss K et al (2018) MRI biomarkers of proximal nerve injury in CIDP. Ann Clin Transl Neurol 5:19–28. https://doi.org/10.1002/acn3.502 |t Ann Clin Transl Neurol |v 5 |y 2018 |
| 999 | C | 5 | |a 10.1002/mus.25368 |9 -- missing cx lookup -- |1 T Ishikawa |p 483 - |2 Crossref |u Ishikawa T, Asakura K, Mizutani Y et al (2017) MR neurography for the evaluation of CIDP. Muscle Nerve 55:483–489. https://doi.org/10.1002/mus.25368 |t Muscle Nerve |v 55 |y 2017 |
| 999 | C | 5 | |a 10.1148/radiol.14132837 |9 -- missing cx lookup -- |1 P Bäumer |p 185 - |2 Crossref |u Bäumer P, Pham M, Ruetters M et al (2014) Peripheral neuropathy: detection with diffusion-tensor imaging. Radiology 273:185–193. https://doi.org/10.1148/radiol.14132837 |t Radiology |v 273 |y 2014 |
| 999 | C | 5 | |a 10.1148/radiol.12111403 |9 -- missing cx lookup -- |1 R Guggenberger |p 194 - |2 Crossref |u Guggenberger R, Markovic D, Eppenberger P et al (2012) Assessment of median nerve with MR neurography by using diffusion-tensor imaging: normative and pathologic diffusion values. Radiology 265:194–203. https://doi.org/10.1148/radiol.12111403 |t Radiology |v 265 |y 2012 |
| 999 | C | 5 | |a 10.1007/s00415-019-09224-0 |9 -- missing cx lookup -- |1 C Schneider |p 975 - |2 Crossref |u Schneider C, Sprenger A, Weiss K et al (2019) MRI detects peripheral nerve and adjacent muscle pathology in non-systemic vasculitic neuropathy (NSVN). J Neurol 266:975–981. https://doi.org/10.1007/s00415-019-09224-0 |t J Neurol |v 266 |y 2019 |
| 999 | C | 5 | |a 10.3389/fnins.2021.682126 |1 T Lichtenstein |9 -- missing cx lookup -- |2 Crossref |u Lichtenstein T, Sprenger A, Weiss K et al (2021) MRI DTI and PDFF as biomarkers for lower motor neuron degeneration in ALS. Front Neurosci. https://doi.org/10.3389/fnins.2021.682126 |t Front Neurosci |y 2021 |
| 999 | C | 5 | |a 10.1016/j.jns.2020.117067 |1 A Barp |9 -- missing cx lookup -- |2 Crossref |u Barp A, Carraro E, Albamonte E et al (2020) Muscle MRI in two SMA patients on nusinersen treatment: a two years follow-up. J Neurol Sci 417:117067. https://doi.org/10.1016/j.jns.2020.117067 |t J Neurol Sci |v 417 |y 2020 |
| 999 | C | 5 | |a 10.1016/j.nmd.2014.01.003 |9 -- missing cx lookup -- |1 E Mazzone |p 347 - |2 Crossref |u Mazzone E, De Sanctis R, Fanelli L et al (2014) Hammersmith functional motor scale and motor function measure-20 in non ambulant SMA patients. Neuromuscul Disord 24:347–352. https://doi.org/10.1016/j.nmd.2014.01.003 |t Neuromuscul Disord |v 24 |y 2014 |
| 999 | C | 5 | |a 10.1007/s00330-014-3552-8 |9 -- missing cx lookup -- |1 JM Kasper |p 1672 - |2 Crossref |u Kasper JM, Wadhwa V, Scott KM et al (2015) SHINKEI—a novel 3D isotropic MR neurography technique: technical advantages over 3DIRTSE-based imaging. Eur Radiol 25:1672–1677. https://doi.org/10.1007/s00330-014-3552-8 |t Eur Radiol |v 25 |y 2015 |
| 999 | C | 5 | |a 10.1002/jmri.25076 |9 -- missing cx lookup -- |1 B Cervantes |p 789 - |2 Crossref |u Cervantes B, Bauer JS, Zibold F et al (2016) Imaging of the lumbar plexus: optimized refocusing flip angle train design for 3D TSE. J Magn Reson Imaging 43:789–799. https://doi.org/10.1002/jmri.25076 |t J Magn Reson Imaging |v 43 |y 2016 |
| 999 | C | 5 | |a 10.1007/s00062-015-0412-0 |9 -- missing cx lookup -- |1 J Kollmer |p 283 - |2 Crossref |u Kollmer J, Bendszus M, Pham M (2015) MR neurography: diagnostic imaging in the PNS. Clin Neuroradiol 25:283–289. https://doi.org/10.1007/s00062-015-0412-0 |t Clin Neuroradiol |v 25 |y 2015 |
| 999 | C | 5 | |a 10.1016/j.nmd.2016.04.009 |9 -- missing cx lookup -- |1 D Fischer |p 414 - |2 Crossref |u Fischer D, Hafner P, Rubino D et al (2016) The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: a cross-sectional study. Neuromuscul Disord 26:414–422. https://doi.org/10.1016/j.nmd.2016.04.009 |t Neuromuscul Disord |v 26 |y 2016 |
| 999 | C | 5 | |a 10.1002/jmri.27032 |9 -- missing cx lookup -- |1 S Schlaeger |p 1727 - |2 Crossref |u Schlaeger S, Weidlich D, Klupp E et al (2020) Water T2 mapping in fatty infiltrated thigh muscles of patients with neuromuscular diseases using a T2-prepared 3D turbo spin echo with SPAIR. J Magn Reson Imaging 51:1727–1736. https://doi.org/10.1002/jmri.27032 |t J Magn Reson Imaging |v 51 |y 2020 |
| 999 | C | 5 | |a 10.2174/1566524016666161128113338 |9 -- missing cx lookup -- |1 AL Nash |p 779 - |2 Crossref |u Nash AL, Burns KJ, Warman Chardon J et al (2017) Spinal muscular atrophy: more than a disease of motor neurons? Curr Mol Med 16:779–792. https://doi.org/10.2174/1566524016666161128113338 |t Curr Mol Med |v 16 |y 2017 |
| 999 | C | 5 | |a 10.1007/s10545-015-9825-9 |9 -- missing cx lookup -- |1 PG Carlier |p 565 - |2 Crossref |u Carlier PG, Azzabou N, de Sousa PL et al (2015) Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients. J Inherit Metab Dis 38:565–572. https://doi.org/10.1007/s10545-015-9825-9 |t J Inherit Metab Dis |v 38 |y 2015 |
| 999 | C | 5 | |a 10.21037/QIMS-20-39 |1 H Reyngoudt |9 -- missing cx lookup -- |2 Crossref |u Reyngoudt H, Marty B, De Almeida Araújo EC et al (2020) Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and 31P nuclear magnetic resonance spectroscopy. Quant Imaging Med Surg. https://doi.org/10.21037/QIMS-20-39 |t Quant Imaging Med Surg |y 2020 |
| 999 | C | 5 | |a 10.1016/j.expneurol.2009.10.012 |9 -- missing cx lookup -- |1 HC Lehmann |p 238 - |2 Crossref |u Lehmann HC, Zhang J, Mori S, Sheikh KA (2010) Diffusion tensor imaging to assess axonal regeneration in peripheral nerves. Exp Neurol 223:238–244. https://doi.org/10.1016/j.expneurol.2009.10.012 |t Exp Neurol |v 223 |y 2010 |
| 999 | C | 5 | |a 10.1002/ar.1092150111 |9 -- missing cx lookup -- |1 H Schmalbruch |p 71 - |2 Crossref |u Schmalbruch H (1986) Fiber composition of the rat sciatic nerve. Anat Rec 215:71–81 |t Anat Rec |v 215 |y 1986 |
| 999 | C | 5 | |a 10.2214/AJR.12.9230 |1 KA Cauley |9 -- missing cx lookup -- |2 Crossref |u Cauley KA, Filippi CG (2013) Diffusion-tensor imaging of small nerve bundles: cranial nerves, peripheral nerves, distal spinal cord, and lumbar nerve roots—clinical applications. Am J Roentgenol. https://doi.org/10.2214/AJR.12.9230 |t Am J Roentgenol |y 2013 |
| 999 | C | 5 | |a 10.1007/S00330-008-0971-4/FIGURES/6 |9 -- missing cx lookup -- |1 C Khalil |p 2283 - |2 Crossref |u Khalil C, Hancart C, Le Thuc V et al (2008) Diffusion tensor imaging and tractography of the median nerve in carpal tunnel syndrome: preliminary results. Eur Radiol 18:2283–2291. https://doi.org/10.1007/S00330-008-0971-4/FIGURES/6 |t Eur Radiol |v 18 |y 2008 |
| 999 | C | 5 | |a 10.3233/JND-190424 |9 -- missing cx lookup -- |1 DC Schorling |p 1 - |2 Crossref |u Schorling DC, Pechmann A, Kirschner J (2020) Advances in treatment of spinal muscular atrophy—new phenotypes, new challenges, new implications for care. J Neuromuscul Dis 7:1. https://doi.org/10.3233/JND-190424 |t J Neuromuscul Dis |v 7 |y 2020 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|